相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Borax regulates iron chaperone- and autophagy-mediated ferroptosis pathway in glioblastoma cells
Ceyhan Hacioglu et al.
ENVIRONMENTAL TOXICOLOGY (2023)
Design and discovery of novel dipeptide boronic acid ester proteasome inhibitors, an oral slowly-released prodrug for the treatment of multiple myeloma
Xueyuan Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
Calcium fructoborate regulate colon cancer (Caco-2) cytotoxicity through modulation of apoptosis
Mehmet A. Kisacam et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2022)
Boric acid suppresses cell proliferation by TNF signaling pathway mediated apoptosis in SW-480 human colon cancer line
Murat Sevimli et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2022)
Boronic Acid as a Promising Class of Chemical Entity for Development of Clinical Medicine for Targeted Therapy of Cancer
Takumi Watanabe et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2022)
Brain Boron Level, DNA Content, and Myeloperoxidase Activity of Metformin-Treated Rats in Diabetes and Prostate Cancer Model
Armagan Begum Ozel et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2022)
Natural source, bioactivity and synthesis of 3-Arylcoumarin derivatives
Qiang Zhang et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
Anti-cancer effect of boron derivatives on small-cell lung cancer
Emre Cebeci et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2022)
Inhibitors of glucosamine-6-phosphate synthase as potential antimicrobials or antidiabetics - synthesis and properties
Joanna Stefaniak et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2022)
3-Thienylboronic Acid as a Receptor for Diol-Containing Compounds: A Study by Isothermal Titration Calorimetry
Yulia Efremenko et al.
CHEMOSENSORS (2022)
In Vivo Assessment of the Effect of Hexagonal Boron Nitride Nanoparticles on Biochemical, Histopathological, Oxidant and Antioxidant Status
Fatih Kar et al.
JOURNAL OF CLUSTER SCIENCE (2021)
Computational Bioactivity Analysis and Bioisosteric Investigation of the Approved Breast Cancer Drugs Proposed New Design Drug Compounds: Increased Bioactivity Coming with Silicon and Boron
Esma Eryilmaz Dogan
LETTERS IN DRUG DESIGN & DISCOVERY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Boron Neutron Capture Therapy: A Review of Clinical Applications
Timothy D. Malouff et al.
FRONTIERS IN ONCOLOGY (2021)
The Use of In Silico Tools for the Toxicity Prediction of Potential Inhibitors of SARS-CoV-2
Varsha Bhat et al.
ATLA-ALTERNATIVES TO LABORATORY ANIMALS (2021)
High Concentrations of Boric Acid Trigger Concentration-Dependent Oxidative Stress, Apoptotic Pathways and Morphological Alterations in DU-145 Human Prostate Cancer Cell Line
Ceyhan Hacioglu et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2020)
Reactive Oxygen Species (ROS)-Sensitive Prodrugs of the Tyrosine Kinase Inhibitor Crizotinib
Bjoern Bielec et al.
MOLECULES (2020)
Self-assembly of oxidation-responsive polyethylene glycol-paclitaxel prodrug for cancer chemotherapy
Chengyuan Dong et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Discovery of Peptide Boronate Derivatives as Histone Deacetylase and Proteasome Dual Inhibitors for Overcoming Bortezomib Resistance of Multiple Myeloma
Yi Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design and discovery of boronic acid drugs
Jessica Plescia et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment
Hichem Maslah et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Pivotal role of boron supplementation on bone health: A narrative review
Mariangela Rondanelli et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2020)
Evaluation of the Anti-cancer and Biological Effects of Boric Acid on Colon Cancer Cell Line
Ayse Cigel et al.
MEANDROS MEDICAL AND DENTAL JOURNAL (2020)
Use of mechanistic information to derive chemical-specific adjustment factors - Refinement of risk assessment
C. Smeraldi et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2020)
Preclinical study of boron neutron capture therapy for bone metastasis using human breast cancer cell lines
Tooru Andoh et al.
APPLIED RADIATION AND ISOTOPES (2020)
Design, Synthesis, and Structure-Activity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents
Jiong Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Boron in drug design: Recent advances in the development of new therapeutic agents
Guilherme Felipe Santos Fernandes et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
Meletios A. Dimopoulos et al.
EUROPEAN JOURNAL OF CANCER (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Enhanced Tumor Selectivity of 5-Fluorouracil Using a Reactive Oxygen Species-Activated Prodrug Approach
Yong Ai et al.
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Discovery of a novel dipeptidyl boronic acid proteasome inhibitor for the treatment of multiple myeloma and triple- negative breast cancer
Meng Lei et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2019)
Boronic acids as building blocks for the construction of therapeutically useful bioconjugates
Joao P. M. Antonio et al.
CHEMICAL SOCIETY REVIEWS (2019)
Prodrug strategies for targeted therapy triggered by reactive oxygen species
Jorge Peiro Cadahia et al.
MEDCHEMCOMM (2019)
A dithiocarbamate-based H2O2-responsive prodrug for combinational chemotherapy and oxidative stress amplification therapy
Qingqing Pan et al.
CHEMICAL COMMUNICATIONS (2019)
Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability
Changde Zhang et al.
PHARMACEUTICALS (2019)
Mild, Efficient, and Regioselective Synthesis of Diiodophenylboronic Acid Derivatives via Metal-Iodine Exchange of 5-Substituted 1,2,3-Triiodoarenes
Raed M. Al-Zoubi et al.
SYNTHESIS-STUTTGART (2018)
Self-immolative chemistry in nanomedicine
M. Gisbert-Garzaran et al.
CHEMICAL ENGINEERING JOURNAL (2018)
Small molecule KDM4s inhibitors as anti-cancer agents
Hongzhi Lin et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Zinc binding groups for histone deacetylase inhibitors
Lei Zhang et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
The safety of bortezomib for the treatment of multiple myeloma
Guldane Cengiz Seval et al.
EXPERT OPINION ON DRUG SAFETY (2018)
Tumor Mutation Burden as a Biomarker in Resected Non-Small-Cell Lung Cancer
Siddhartha Devarakonda et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma
Richard Arkwright et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
Urea-containing peptide boronic acids as potent proteasome inhibitors
Li-Qiang Han et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design, Synthesis and X-ray Crystal Structure of Iodinated Benzoboroxole Derivatives by Consecutive Metal-Iodine Exchange of 3,4,5-Triiodoanisole
Raed M. Al-Zoubi et al.
EUROPEAN JOURNAL OF ORGANIC CHEMISTRY (2017)
Phase I/II study of the novel proteasome inhibitor delanzomib (CEP-18770) for relapsed and refractory multiple myeloma
Dan T. Vogl et al.
LEUKEMIA & LYMPHOMA (2017)
Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses
Neeraj Gupta et al.
TARGETED ONCOLOGY (2017)
A Tumor-Specific Cascade Amplification Drug Release Nanoparticle for Overcoming Multidrug Resistance in Cancers
Mingzhou Ye et al.
ADVANCED MATERIALS (2017)
Ratiometric Fluorescent Probes for the Detection of Reactive Oxygen Species
Diana Andina et al.
CHEMISTRY-A EUROPEAN JOURNAL (2017)
Assessment of 10B concentration in boron neutron capture therapy: potential of image-guided therapy using 18FBPA PET
Eku Shimosegawa et al.
ANNALS OF NUCLEAR MEDICINE (2016)
Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1
Sabin Llona-Minguez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Alcohol, Aldehyde, and Ketone Liberation and Intracellular Cargo Release through Peroxide-Mediated α-Boryl Ether Fragmentation
Ramsey D. Hanna et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Boronic prodrug of endoxifen as an effective hormone therapy for breast cancer
Changde Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2
Printip Wongthai et al.
CANCER SCIENCE (2015)
Design, Synthesis, and Characterization of Small-Molecule Reagents That Cooperatively Provide Dual Readouts for Triaging and, When Necessary, Quantifying Point-of-Need Enzyme Assays
Adam D. Brooks et al.
JOURNAL OF ORGANIC CHEMISTRY (2015)
Disturbing Trends in Physician Burnout and Satisfaction With Work-Life Balance: Dealing With Malady Among the Nation's Healers
Dan Ariely et al.
MAYO CLINIC PROCEEDINGS (2015)
Boric acid induces cytoplasmic stress granule formation, eIF2α phosphorylation, and ATF4 in prostate DU-145 cells
Kimberly A. Henderson et al.
BIOMETALS (2015)
An Activatable Prodrug for the Treatment of Metastatic Tumors
Eun-Joong Kim et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Update on human health effects of boron
Forrest H. Nielsen
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2014)
Treatment of Non-Transplant Patients with Multiple Myeloma: Routine Treatment by Office-Based Haematologists in Germany - Data from the Prospective Tumour Registry Lymphatic Neoplasms (TLN)
Wolfgang Knauf et al.
ONCOLOGY RESEARCH AND TREATMENT (2014)
In silico investigations of potential anabolic treatments in multiple myeloma-induced bone disease
Yan Wang et al.
BONE (2013)
Substituent Effects on Oxidation-Induced Formation of Quinone Methides from Arylboronic Ester Precursors
Sheng Cao et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Drug rechallenge and treatment beyond progression-implications for drug resistance
Elizabeth A. Kuczynski et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Boron-Containing Compounds as Preventive and Chemotherapeutic Agents for Cancer
Romulus I. Scorei et al.
Anti-Cancer Agents in Medicinal Chemistry (2012)
Boronate Probes as Diagnostic Tools for Real Time Monitoring of Peroxynitrite and Hydroperoxides
Jacek Zielonka et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Disclosing the Structure/Activity Correlation in Trivalent Boron-Containing Compounds: A Tendency Map
Jessica Cid et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
New classes of carborane-appended 5-thio-D-glucopyranose derivatives
Rashmirekha Satapathy et al.
DALTON TRANSACTIONS (2012)
Dietary boron: Progress in establishing essential roles in human physiology
Curtiss D. Hunt
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2012)
European Perspective on Multiple Myeloma Treatment Strategies: Update Following Recent Congresses
Heinz Ludwig et al.
ONCOLOGIST (2012)
ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage
Xiaohua Peng et al.
THERAPEUTIC DELIVERY (2012)
Calcium Fructoborate-Potential Anti-inflammatory Agent
Romulus Ion Scorei et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2011)
Effect of Boron on Osteogenic Differentiation of Human Bone Marrow Stromal Cells
Xiaozhou Ying et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2011)
Principles of early drug discovery
J. P. Hughes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Reaction between Peroxynitrite and Boronates: EPR Spin-Trapping, HPLC Analyses, and Quantum Mechanical Study of the Free Radical Pathway
Adam Sikora et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
D. Chen et al.
CURRENT CANCER DRUG TARGETS (2011)
Hydrogen Peroxide Inducible DNA Cross-Linking Agents: Targeted Anticancer Prodrugs
Yunyan Kuang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines
Mohammad Reza Naghii et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2011)
Phenylboronic acid is a more potent inhibitor than boric acid of key signaling networks involved in cancer cell migration
Erin M. McAuley et al.
CELL ADHESION & MIGRATION (2011)
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
J. -L. Harousseau et al.
ANNALS OF ONCOLOGY (2010)
Boron-containing phenoxyacetanilide derivatives as hypoxia-inducible factor (HIF)-1α inhibitors
Kazuki Shimizu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy
Lawrence R. Dick et al.
DRUG DISCOVERY TODAY (2010)
Risk of colorectal cancer in men on long-term androgen deprivation therapy for prostate cancer
Silke Gillessen et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Estrogen and Xenoestrogens in Breast Cancer
S. V. Fernandez et al.
TOXICOLOGIC PATHOLOGY (2010)
Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis
Tsutomu Akama et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
The proteasome: Overview of structure and functions
Keiji Tanaka
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2009)
Potent and selective peptidyl boronic acid inhibitors of the serine protease Prostate-Specific Antigen
Aaron M. LeBeau et al.
CHEMISTRY & BIOLOGY (2008)
Boron intake and prostate cancer risk
Alejandro Gonzalez et al.
CANCER CAUSES & CONTROL (2007)
Talabostat
Charles Casey Cunningham
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
The role of estrogen in the initiation of breast cancer
J. Russo et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2006)
Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2690), for the potential treatment of onychomycosis
Stephen J. Baker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Identification of borinic esters as inhibitors of bacterial cell growth and bacterial methyltransferases, CcrM and MenH
SJ Benkovic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Boron neutron capture therapy of cancer: Current status and future prospects
RF Barth et al.
CLINICAL CANCER RESEARCH (2005)
Boric acid inhibits human prostate cancer cell proliferation
WT Barranco et al.
CANCER LETTERS (2004)
Functional correlation of trophinin expression with the malignancy of testicular germ cell tumor
S Hatakeyama et al.
CANCER RESEARCH (2004)
Approval summary for bortezomib for injection in the treatment of multiple myeloma
PF Bross et al.
CLINICAL CANCER RESEARCH (2004)
Synthesis and evaluation of oxazaborolidines for antibacterial activity against Streptococcus mutans
A Jabbour et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it
R Rashmi et al.
CARCINOGENESIS (2004)
Boron supplementation inhibits the growth and local expression of IGF-1 in human prostate adenocarcinoma (LNCaP) tumors in nude mice
MT Gallardo-Williams et al.
TOXICOLOGIC PATHOLOGY (2004)
Men with colorectal cancer are predisposed to prostate cancer
AR Moot et al.
ANZ JOURNAL OF SURGERY (2003)
Current status of the molecular genetics of human prostatic adenocarcinomas
D Karan et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
分享论文
